speb/financial-data huggingface dataset:
BCAX balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 712884000.00
BCAX cash_flow (annual, 2024-12-31) — Amortization Of Securities: 0.00
BCAX cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 0.00
BCAX income_statement (annual, 2024-12-31) — Basic Average Shares: 16805524.00
BCAX income_statement (annual, 2024-12-31) — Basic EPS: -4.05
BCAX cash_flow (annual, 2024-12-31) — Beginning Cash Position: 230440000.00
BCAX cash_flow (annual, 2024-12-31) — Capital Expenditure: -71000.00
BCAX cash_flow (quarterly, 2024-12-31) — Capital Expenditure: -40000.00
BCAX balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 738000.00
BCAX balance_sheet (annual, 2024-12-31) — Capital Stock: 7000.00
BCAX balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 489711000.00
BCAX balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 489711000.00
BCAX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 334031000.00
BCAX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -9000.00
BCAX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -74751000.00
BCAX cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: 81000.00
BCAX cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 2637000.00
BCAX cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -16850000.00
BCAX cash_flow (annual, 2024-12-31) — Change In Working Capital: -14132000.00
BCAX cash_flow (annual, 2024-12-31) — Changes In Cash: 259271000.00
BCAX balance_sheet (annual, 2024-12-31) — Common Stock: 7000.00
BCAX balance_sheet (annual, 2024-12-31) — Common Stock Equity: 491875000.00
BCAX cash_flow (annual, 2024-12-31) — Common Stock Issuance: 332427000.00
BCAX cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: -1052000.00
BCAX balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 9792000.00
BCAX balance_sheet (annual, 2024-12-31) — Current Assets: 502533000.00
BCAX balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 607000.00
BCAX balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 607000.00
BCAX balance_sheet (annual, 2024-12-31) — Current Liabilities: 17990000.00
BCAX cash_flow (annual, 2024-12-31) — Depreciation: 56000.00
BCAX cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 56000.00
BCAX cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 56000.00
BCAX income_statement (annual, 2024-12-31) — Diluted Average Shares: 16805524.00
BCAX income_statement (annual, 2024-12-31) — Diluted EPS: -4.05
BCAX income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -67995000.00
BCAX income_statement (annual, 2024-12-31) — EBIT: -82389000.00
BCAX income_statement (annual, 2024-12-31) — EBITDA: -82333000.00
BCAX cash_flow (annual, 2024-12-31) — End Cash Position: 489711000.00
BCAX cash_flow (annual, 2024-12-31) — Financing Cash Flow: 334031000.00
BCAX cash_flow (annual, 2024-12-31) — Free Cash Flow: -74822000.00
BCAX balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 0.00
BCAX balance_sheet (quarterly, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 0.00
BCAX income_statement (annual, 2024-12-31) — General And Administrative Expense: 18770000.00
BCAX balance_sheet (annual, 2024-12-31) — Gross PPE: 845000.00
BCAX income_statement (annual, 2024-12-31) — Interest Income: 14581000.00
BCAX income_statement (annual, 2024-12-31) — Interest Income Non Operating: 14581000.00
BCAX balance_sheet (annual, 2024-12-31) — Invested Capital: 491875000.00
BCAX cash_flow (annual, 2024-12-31) — Investing Cash Flow: -9000.00
BCAX cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 332427000.00
BCAX cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: -1052000.00
BCAX balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 131000.00
BCAX balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 131000.00
BCAX cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 332427000.00
BCAX cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: -1052000.00
BCAX income_statement (annual, 2024-12-31) — Net Income: -67995000.00
BCAX income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -67995000.00
BCAX income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -67995000.00
BCAX income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -67995000.00
BCAX income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -67995000.00
BCAX cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -67995000.00
BCAX income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -67995000.00
BCAX income_statement (annual, 2024-12-31) — Net Interest Income: 14581000.00
BCAX cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 0.00
BCAX income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 14581000.00
BCAX balance_sheet (annual, 2024-12-31) — Net PPE: 845000.00
BCAX cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -9000.00
BCAX cash_flow (annual, 2024-12-31) — Net Preferred Stock Issuance: 0.00
BCAX cash_flow (quarterly, 2024-12-31) — Net Preferred Stock Issuance: 0.00
BCAX balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 491875000.00
BCAX income_statement (annual, 2024-12-31) — Normalized EBITDA: -82333000.00
BCAX income_statement (annual, 2024-12-31) — Normalized Income: -67995000.00
BCAX cash_flow (annual, 2024-12-31) — Operating Cash Flow: -74751000.00
BCAX income_statement (annual, 2024-12-31) — Operating Income: -82389000.00
BCAX income_statement (annual, 2024-12-31) — Operating Revenue: 0.00
BCAX balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 54440013.00
BCAX balance_sheet (annual, 2024-12-31) — Other Current Assets: 12822000.00
BCAX income_statement (annual, 2024-12-31) — Other Gand A: 6225000.00
BCAX cash_flow (annual, 2024-12-31) — Other Non Cash Items: -77000.00
BCAX balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 6618000.00
BCAX balance_sheet (annual, 2024-12-31) — Other Properties: 845000.00
BCAX balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 0.00
BCAX balance_sheet (quarterly, 2024-12-31) — Other Short Term Investments: 0.00
BCAX balance_sheet (annual, 2024-12-31) — Payables: 4508000.00
BCAX balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 14300000.00
BCAX balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 3083000.00
BCAX balance_sheet (annual, 2024-12-31) — Preferred Securities Outside Stock Equity: 0.00
BCAX balance_sheet (quarterly, 2024-12-31) — Preferred Securities Outside Stock Equity: 0.00
BCAX balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
BCAX cash_flow (annual, 2024-12-31) — Preferred Stock Issuance: 0.00
BCAX cash_flow (quarterly, 2024-12-31) — Preferred Stock Issuance: 0.00
BCAX income_statement (annual, 2024-12-31) — Pretax Income: -67808000.00
BCAX cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 1604000.00
BCAX cash_flow (annual, 2024-12-31) — Purchase Of Investment: 0.00
BCAX cash_flow (annual, 2024-12-31) — Purchase Of PPE: -71000.00
BCAX income_statement (annual, 2024-12-31) — Reconciled Depreciation: 56000.00
BCAX income_statement (annual, 2024-12-31) — Research And Development: 63619000.00
BCAX balance_sheet (annual, 2024-12-31) — Retained Earnings: -221016000.00
BCAX income_statement (annual, 2024-12-31) — Salaries And Wages: 12545000.00
BCAX cash_flow (annual, 2024-12-31) — Sale Of PPE: 62000.00
BCAX cash_flow (quarterly, 2024-12-31) — Sale Of PPE: 0.00
BCAX income_statement (annual, 2024-12-31) — Selling General And Administration: 18770000.00
BCAX balance_sheet (annual, 2024-12-31) — Share Issued: 54440013.00
BCAX cash_flow (annual, 2024-12-31) — Stock Based Compensation: 7397000.00
BCAX balance_sheet (annual, 2024-12-31) — Stockholders Equity: 491875000.00
BCAX balance_sheet (annual, 2024-12-31) — Tangible Book Value: 491875000.00
BCAX income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
BCAX income_statement (annual, 2024-12-31) — Tax Provision: 187000.00
BCAX income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
BCAX balance_sheet (annual, 2024-12-31) — Total Assets: 509996000.00
BCAX balance_sheet (annual, 2024-12-31) — Total Capitalization: 491875000.00
BCAX balance_sheet (annual, 2024-12-31) — Total Debt: 738000.00
BCAX balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 491875000.00
BCAX income_statement (annual, 2024-12-31) — Total Expenses: 82389000.00
BCAX balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 18121000.00
BCAX balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 7463000.00
BCAX balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 131000.00
BCAX income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -82389000.00
BCAX balance_sheet (annual, 2024-12-31) — Working Capital: 484543000.00
BCAX income_statement (quarterly, 2025-03-31) — +Operating Expense: 41788000.00
BCAX income_statement (quarterly, 2025-03-31) — +Total Revenue: 0.00
BCAX balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 2740000.00
BCAX balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 716812000.00
BCAX cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: 0.00
BCAX income_statement (quarterly, 2025-03-31) — Basic Average Shares: 54456515.00
BCAX income_statement (quarterly, 2025-03-31) — Basic EPS: -0.68
BCAX cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 489711000.00
BCAX balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 591000.00
BCAX balance_sheet (quarterly, 2025-03-31) — Capital Stock: 7000.00
BCAX balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 462065000.00
BCAX balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 462065000.00
BCAX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 460000.00
BCAX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 0.00
BCAX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -28106000.00
BCAX cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -147000.00
BCAX cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 1163000.00
BCAX cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 4116000.00
BCAX cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 5132000.00
BCAX cash_flow (quarterly, 2025-03-31) — Changes In Cash: -27646000.00
BCAX balance_sheet (quarterly, 2025-03-31) — Common Stock: 7000.00
BCAX balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 458957000.00
BCAX cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
BCAX balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 14113000.00
BCAX balance_sheet (quarterly, 2025-03-31) — Current Assets: 470754000.00
BCAX balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 591000.00
BCAX balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 591000.00
BCAX balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 19120000.00
BCAX cash_flow (quarterly, 2025-03-31) — Depreciation: 19000.00
BCAX cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 19000.00
BCAX cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 19000.00
BCAX income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 54456515.00
BCAX income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.68
BCAX income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -36846000.00
BCAX income_statement (quarterly, 2025-03-31) — EBIT: -41788000.00
BCAX income_statement (quarterly, 2025-03-31) — EBITDA: -41769000.00
BCAX cash_flow (quarterly, 2025-03-31) — End Cash Position: 462065000.00
BCAX cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 460000.00
BCAX cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -28106000.00
BCAX income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 7455000.00
BCAX balance_sheet (quarterly, 2025-03-31) — Gross PPE: 688000.00
BCAX cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 72000.00
BCAX income_statement (quarterly, 2025-03-31) — Interest Income: 5014000.00
BCAX income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 5014000.00
BCAX balance_sheet (quarterly, 2025-03-31) — Invested Capital: 458957000.00
BCAX cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 0.00
BCAX cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
BCAX balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 0.00
BCAX balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 0.00
BCAX cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
BCAX income_statement (quarterly, 2025-03-31) — Net Income: -36846000.00
BCAX income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -36846000.00
BCAX income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -36846000.00
BCAX income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -36846000.00
BCAX income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -36846000.00
BCAX cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -36846000.00
BCAX income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -36846000.00
BCAX income_statement (quarterly, 2025-03-31) — Net Interest Income: 5014000.00
BCAX cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 0.00
BCAX income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 5014000.00
BCAX balance_sheet (quarterly, 2025-03-31) — Net PPE: 688000.00
BCAX cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: 0.00
BCAX balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 458957000.00
BCAX income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -41769000.00
BCAX income_statement (quarterly, 2025-03-31) — Normalized Income: -36846000.00
BCAX cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -28106000.00
BCAX income_statement (quarterly, 2025-03-31) — Operating Income: -41788000.00
BCAX income_statement (quarterly, 2025-03-31) — Operating Revenue: 0.00
BCAX balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 54528975.00
BCAX balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 8689000.00
BCAX income_statement (quarterly, 2025-03-31) — Other Gand A: 2623000.00
BCAX cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 138000.00
BCAX balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 6635000.00
BCAX balance_sheet (quarterly, 2025-03-31) — Other Properties: 688000.00
BCAX balance_sheet (quarterly, 2025-03-31) — Payables: 2740000.00
BCAX balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 16853000.00
BCAX balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 1676000.00
BCAX balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
BCAX income_statement (quarterly, 2025-03-31) — Pretax Income: -36774000.00
BCAX cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 460000.00
BCAX cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: 0.00
BCAX income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 19000.00
BCAX income_statement (quarterly, 2025-03-31) — Research And Development: 34333000.00
BCAX balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -257862000.00
BCAX income_statement (quarterly, 2025-03-31) — Salaries And Wages: 4832000.00
BCAX cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 0.00
BCAX cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 0.00
BCAX income_statement (quarterly, 2025-03-31) — Selling General And Administration: 7455000.00
BCAX balance_sheet (quarterly, 2025-03-31) — Share Issued: 54528975.00
BCAX cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 3451000.00
BCAX balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 458957000.00
BCAX balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 458957000.00
BCAX income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
BCAX income_statement (quarterly, 2025-03-31) — Tax Provision: 72000.00
BCAX income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
BCAX balance_sheet (quarterly, 2025-03-31) — Total Assets: 478077000.00
BCAX balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 458957000.00
BCAX balance_sheet (quarterly, 2025-03-31) — Total Debt: 591000.00
BCAX balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 458957000.00
BCAX income_statement (quarterly, 2025-03-31) — Total Expenses: 41788000.00
BCAX balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 19120000.00
BCAX balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 7323000.00
BCAX balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 0.00
BCAX income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -41788000.00
BCAX balance_sheet (quarterly, 2025-03-31) — Working Capital: 451634000.00
BCAX income_statement (quarterly, 2025-06-30) — +Operating Expense: 32018000.00
BCAX income_statement (quarterly, 2025-06-30) — +Total Revenue: 0.00
BCAX balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 2911000.00
BCAX balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 720439000.00
BCAX income_statement (quarterly, 2025-06-30) — Basic Average Shares: 54539230.00
BCAX income_statement (quarterly, 2025-06-30) — Basic EPS: -0.50
BCAX cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 462065000.00
BCAX balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 2238000.00
BCAX balance_sheet (quarterly, 2025-06-30) — Capital Stock: 7000.00
BCAX balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 436606000.00
BCAX balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 436606000.00
BCAX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 135000.00
BCAX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 0.00
BCAX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -25594000.00
BCAX cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -176000.00
BCAX cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -2379000.00
BCAX cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 627000.00
BCAX cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -1928000.00
BCAX cash_flow (quarterly, 2025-06-30) — Changes In Cash: -25459000.00
BCAX balance_sheet (quarterly, 2025-06-30) — Common Stock: 7000.00
BCAX balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 435196000.00
BCAX balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 11076000.00
BCAX balance_sheet (quarterly, 2025-06-30) — Current Assets: 444391000.00
BCAX balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 1074000.00
BCAX balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 1074000.00
BCAX balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 17227000.00
BCAX cash_flow (quarterly, 2025-06-30) — Depreciation: 19000.00
BCAX cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 19000.00
BCAX cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 19000.00
BCAX income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 54539230.00
BCAX income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.50
BCAX income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -27388000.00
BCAX income_statement (quarterly, 2025-06-30) — EBIT: -32018000.00
BCAX income_statement (quarterly, 2025-06-30) — EBITDA: -31999000.00
BCAX cash_flow (quarterly, 2025-06-30) — End Cash Position: 436606000.00
BCAX cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 135000.00
BCAX cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -25594000.00
BCAX income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 7220000.00
BCAX balance_sheet (quarterly, 2025-06-30) — Gross PPE: 2354000.00
BCAX cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 52000.00
BCAX income_statement (quarterly, 2025-06-30) — Interest Income: 4682000.00
BCAX income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 4682000.00
BCAX balance_sheet (quarterly, 2025-06-30) — Invested Capital: 435196000.00
BCAX cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 0.00
BCAX balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 1164000.00
BCAX balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 1164000.00
BCAX income_statement (quarterly, 2025-06-30) — Net Income: -27388000.00
BCAX income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -27388000.00
BCAX income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -27388000.00
BCAX income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -27388000.00
BCAX income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -27388000.00
BCAX cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -27388000.00
BCAX income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -27388000.00
BCAX income_statement (quarterly, 2025-06-30) — Net Interest Income: 4682000.00
BCAX income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 4682000.00
BCAX balance_sheet (quarterly, 2025-06-30) — Net PPE: 2354000.00
BCAX cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: 0.00
BCAX balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 435196000.00
BCAX income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -31999000.00
BCAX income_statement (quarterly, 2025-06-30) — Normalized Income: -27388000.00
BCAX cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -25594000.00
BCAX income_statement (quarterly, 2025-06-30) — Operating Income: -32018000.00
BCAX income_statement (quarterly, 2025-06-30) — Operating Revenue: 0.00
BCAX balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 54556078.00
BCAX balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 7785000.00
BCAX income_statement (quarterly, 2025-06-30) — Other Gand A: 2366000.00
BCAX cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 211000.00
BCAX balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 6842000.00
BCAX balance_sheet (quarterly, 2025-06-30) — Other Properties: 2354000.00
BCAX balance_sheet (quarterly, 2025-06-30) — Payables: 2911000.00
BCAX balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 13987000.00
BCAX balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 2166000.00
BCAX balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
BCAX income_statement (quarterly, 2025-06-30) — Pretax Income: -27336000.00
BCAX cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 135000.00
BCAX cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: 0.00
BCAX income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 19000.00
BCAX income_statement (quarterly, 2025-06-30) — Research And Development: 24798000.00
BCAX balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -285250000.00
BCAX income_statement (quarterly, 2025-06-30) — Salaries And Wages: 4854000.00
BCAX cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 0.00
BCAX income_statement (quarterly, 2025-06-30) — Selling General And Administration: 7220000.00
BCAX balance_sheet (quarterly, 2025-06-30) — Share Issued: 54556078.00
BCAX cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 3492000.00
BCAX balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 435196000.00
BCAX balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 435196000.00
BCAX income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
BCAX income_statement (quarterly, 2025-06-30) — Tax Provision: 52000.00
BCAX income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
BCAX balance_sheet (quarterly, 2025-06-30) — Total Assets: 453587000.00
BCAX balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 435196000.00
BCAX balance_sheet (quarterly, 2025-06-30) — Total Debt: 2238000.00
BCAX balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 435196000.00
BCAX income_statement (quarterly, 2025-06-30) — Total Expenses: 32018000.00
BCAX balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 18391000.00
BCAX balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 9196000.00
BCAX balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 1164000.00
BCAX income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -32018000.00
BCAX balance_sheet (quarterly, 2025-06-30) — Working Capital: 427164000.00
BCAX income_statement (quarterly, 2025-09-30) — +Operating Expense: 40676000.00
BCAX income_statement (quarterly, 2025-09-30) — +Total Revenue: 0.00
BCAX balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 3662000.00
BCAX balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 724489000.00
BCAX income_statement (quarterly, 2025-09-30) — Basic Average Shares: 54563864.00
BCAX income_statement (quarterly, 2025-09-30) — Basic EPS: -0.67
BCAX cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 436606000.00
BCAX balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 1975000.00
BCAX balance_sheet (quarterly, 2025-09-30) — Capital Stock: 7000.00
BCAX balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 171673000.00
BCAX balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 290167000.00
BCAX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 436000.00
BCAX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -236121000.00
BCAX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -29248000.00
BCAX cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -317000.00
BCAX cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 3781000.00
BCAX cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -301000.00
BCAX cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 3163000.00
BCAX cash_flow (quarterly, 2025-09-30) — Changes In Cash: -264933000.00
BCAX balance_sheet (quarterly, 2025-09-30) — Common Stock: 7000.00
BCAX balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 402780000.00
BCAX balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 12281000.00
BCAX balance_sheet (quarterly, 2025-09-30) — Current Assets: 297372000.00
BCAX balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 1095000.00
BCAX balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 1095000.00
BCAX balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 21028000.00
BCAX cash_flow (quarterly, 2025-09-30) — Depreciation: 24000.00
BCAX cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 24000.00
BCAX cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 24000.00
BCAX income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 54563864.00
BCAX income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.67
BCAX income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -36330000.00
BCAX income_statement (quarterly, 2025-09-30) — EBIT: -40676000.00
BCAX income_statement (quarterly, 2025-09-30) — EBITDA: -40652000.00
BCAX cash_flow (quarterly, 2025-09-30) — End Cash Position: 171673000.00
BCAX cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 436000.00
BCAX cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -29290000.00
BCAX balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -136000.00
BCAX income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 7701000.00
BCAX balance_sheet (quarterly, 2025-09-30) — Gross PPE: 2104000.00
BCAX cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 167000.00
BCAX income_statement (quarterly, 2025-09-30) — Interest Income: 4386000.00
BCAX income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 4386000.00
BCAX balance_sheet (quarterly, 2025-09-30) — Invested Capital: 402780000.00
BCAX cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -236121000.00
BCAX balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 117417000.00
BCAX balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 880000.00
BCAX balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 880000.00
BCAX balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 117417000.00
BCAX income_statement (quarterly, 2025-09-30) — Net Income: -36330000.00
BCAX income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -36330000.00
BCAX income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -36330000.00
BCAX income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -36330000.00
BCAX income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -36330000.00
BCAX cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -36330000.00
BCAX income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -36330000.00
BCAX income_statement (quarterly, 2025-09-30) — Net Interest Income: 4386000.00
BCAX income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 4386000.00
BCAX balance_sheet (quarterly, 2025-09-30) — Net PPE: 2104000.00
BCAX cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -42000.00
BCAX balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 402780000.00
BCAX income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -40652000.00
BCAX income_statement (quarterly, 2025-09-30) — Normalized Income: -36330000.00
BCAX cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -29248000.00
BCAX income_statement (quarterly, 2025-09-30) — Operating Income: -40676000.00
BCAX income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
BCAX balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 54612477.00
BCAX balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 7205000.00
BCAX balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -136000.00
BCAX income_statement (quarterly, 2025-09-30) — Other Gand A: 2511000.00
BCAX cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 249000.00
BCAX balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 7795000.00
BCAX balance_sheet (quarterly, 2025-09-30) — Other Properties: 2104000.00
BCAX balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 118494000.00
BCAX balance_sheet (quarterly, 2025-09-30) — Payables: 3662000.00
BCAX balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 15943000.00
BCAX balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 3990000.00
BCAX balance_sheet (quarterly, 2025-09-30) — Preferred Securities Outside Stock Equity: 0.00
BCAX balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
BCAX income_statement (quarterly, 2025-09-30) — Pretax Income: -36290000.00
BCAX cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 436000.00
BCAX cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -42000.00
BCAX income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 24000.00
BCAX income_statement (quarterly, 2025-09-30) — Research And Development: 32975000.00
BCAX balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -321580000.00
BCAX income_statement (quarterly, 2025-09-30) — Salaries And Wages: 5190000.00
BCAX cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 0.00
BCAX income_statement (quarterly, 2025-09-30) — Selling General And Administration: 7701000.00
BCAX balance_sheet (quarterly, 2025-09-30) — Share Issued: 54612477.00
BCAX cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 3614000.00
BCAX balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 402780000.00
BCAX balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 402780000.00
BCAX income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
BCAX income_statement (quarterly, 2025-09-30) — Tax Provision: 40000.00
BCAX income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
BCAX balance_sheet (quarterly, 2025-09-30) — Total Assets: 424688000.00
BCAX balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 402780000.00
BCAX balance_sheet (quarterly, 2025-09-30) — Total Debt: 1975000.00
BCAX balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 402780000.00
BCAX income_statement (quarterly, 2025-09-30) — Total Expenses: 40676000.00
BCAX balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 21908000.00
BCAX balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 127316000.00
BCAX balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 880000.00
BCAX income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -40676000.00
BCAX balance_sheet (quarterly, 2025-09-30) — Working Capital: 276344000.00
BCAX income_statement (annual, 2025-12-31) — +Operating Expense: 155604000.00
BCAX income_statement (quarterly, 2025-12-31) — +Operating Expense: 41122000.00
BCAX income_statement (annual, 2025-12-31) — +Total Revenue: 0.00
BCAX income_statement (quarterly, 2025-12-31) — +Total Revenue: 0.00
BCAX balance_sheet (annual, 2025-12-31) — Accounts Payable: 7793000.00
BCAX balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 7793000.00
BCAX balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 760168000.00
BCAX balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 760168000.00
BCAX cash_flow (annual, 2025-12-31) — Amortization Of Securities: 301000.00
BCAX cash_flow (quarterly, 2025-12-31) — Amortization Of Securities: 269000.00
BCAX income_statement (annual, 2025-12-31) — Basic Average Shares: 54676896.00
BCAX income_statement (quarterly, 2025-12-31) — Basic Average Shares: 55142252.00
BCAX income_statement (annual, 2025-12-31) — Basic EPS: -2.52
BCAX income_statement (quarterly, 2025-12-31) — Basic EPS: -0.68
BCAX cash_flow (annual, 2025-12-31) — Beginning Cash Position: 489711000.00
BCAX cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 171673000.00
BCAX cash_flow (annual, 2025-12-31) — Capital Expenditure: -280000.00
BCAX cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -238000.00
BCAX balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 1710000.00
BCAX balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 1710000.00
BCAX balance_sheet (annual, 2025-12-31) — Capital Stock: 7000.00
BCAX balance_sheet (quarterly, 2025-12-31) — Capital Stock: 7000.00
BCAX balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 96685000.00
BCAX balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 96685000.00
BCAX balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 414801000.00
BCAX balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 414801000.00
BCAX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 32261000.00
BCAX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 31230000.00
BCAX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -318453000.00
BCAX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -82332000.00
BCAX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -106834000.00
BCAX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -23886000.00
BCAX cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -932000.00
BCAX cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -292000.00
BCAX cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 10460000.00
BCAX cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 7895000.00
BCAX cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 5281000.00
BCAX cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 839000.00
BCAX cash_flow (annual, 2025-12-31) — Change In Working Capital: 14809000.00
BCAX cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 8442000.00
BCAX cash_flow (annual, 2025-12-31) — Changes In Cash: -393026000.00
BCAX cash_flow (quarterly, 2025-12-31) — Changes In Cash: -74988000.00
BCAX balance_sheet (annual, 2025-12-31) — Common Stock: 7000.00
BCAX balance_sheet (quarterly, 2025-12-31) — Common Stock: 7000.00
BCAX balance_sheet (annual, 2025-12-31) — Common Stock Equity: 401452000.00
BCAX balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 401452000.00
BCAX cash_flow (annual, 2025-12-31) — Common Stock Issuance: 29498000.00
BCAX cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 29498000.00
BCAX balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 14998000.00
BCAX balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 14998000.00
BCAX balance_sheet (annual, 2025-12-31) — Current Assets: 422053000.00
BCAX balance_sheet (quarterly, 2025-12-31) — Current Assets: 422053000.00
BCAX balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 1117000.00
BCAX balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 1117000.00
BCAX balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 1117000.00
BCAX balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 1117000.00
BCAX balance_sheet (annual, 2025-12-31) — Current Liabilities: 28949000.00
BCAX balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 28949000.00
BCAX cash_flow (annual, 2025-12-31) — Depreciation: 105000.00
BCAX cash_flow (quarterly, 2025-12-31) — Depreciation: 43000.00
BCAX cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 105000.00
BCAX cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 43000.00
BCAX cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 105000.00
BCAX cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 43000.00
BCAX income_statement (annual, 2025-12-31) — Diluted Average Shares: 54676896.00
BCAX income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 55142252.00
BCAX income_statement (annual, 2025-12-31) — Diluted EPS: -2.52
BCAX income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.68
BCAX income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -137950000.00
BCAX income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -37386000.00
BCAX income_statement (annual, 2025-12-31) — EBIT: -155604000.00
BCAX income_statement (quarterly, 2025-12-31) — EBIT: -41122000.00
BCAX income_statement (annual, 2025-12-31) — EBITDA: -155499000.00
BCAX income_statement (quarterly, 2025-12-31) — EBITDA: -41079000.00
BCAX cash_flow (annual, 2025-12-31) — End Cash Position: 96685000.00
BCAX cash_flow (quarterly, 2025-12-31) — End Cash Position: 96685000.00
BCAX cash_flow (annual, 2025-12-31) — Financing Cash Flow: 32261000.00
BCAX cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 31230000.00
BCAX cash_flow (annual, 2025-12-31) — Free Cash Flow: -107114000.00
BCAX cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -24124000.00
BCAX balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 243000.00
BCAX balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 243000.00
BCAX income_statement (annual, 2025-12-31) — General And Administrative Expense: 30508000.00
BCAX income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 8132000.00
BCAX balance_sheet (annual, 2025-12-31) — Gross PPE: 2031000.00
BCAX balance_sheet (quarterly, 2025-12-31) — Gross PPE: 2031000.00
BCAX income_statement (annual, 2025-12-31) — Interest Income: 17871000.00
BCAX income_statement (quarterly, 2025-12-31) — Interest Income: 3789000.00
BCAX income_statement (annual, 2025-12-31) — Interest Income Non Operating: 17871000.00
BCAX income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 3789000.00
BCAX balance_sheet (annual, 2025-12-31) — Invested Capital: 401452000.00
BCAX balance_sheet (quarterly, 2025-12-31) — Invested Capital: 401452000.00
BCAX cash_flow (annual, 2025-12-31) — Investing Cash Flow: -318453000.00
BCAX cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -82332000.00
BCAX cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 29498000.00
BCAX cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 29498000.00
BCAX balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 593000.00
BCAX balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 593000.00
BCAX balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 593000.00
BCAX balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 593000.00
BCAX cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 29498000.00
BCAX cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 29498000.00
BCAX income_statement (annual, 2025-12-31) — Net Income: -137950000.00
BCAX income_statement (quarterly, 2025-12-31) — Net Income: -37386000.00
BCAX income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -137950000.00
BCAX income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -37386000.00
BCAX income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -137950000.00
BCAX income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -37386000.00
BCAX income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -137950000.00
BCAX income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -37386000.00
BCAX income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -137950000.00
BCAX income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -37386000.00
BCAX cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -137950000.00
BCAX cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -37386000.00
BCAX income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -137950000.00
BCAX income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -37386000.00
BCAX income_statement (annual, 2025-12-31) — Net Interest Income: 17871000.00
BCAX income_statement (quarterly, 2025-12-31) — Net Interest Income: 3789000.00
BCAX cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -318173000.00
BCAX cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -82094000.00
BCAX income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 17871000.00
BCAX income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 3789000.00
BCAX balance_sheet (annual, 2025-12-31) — Net PPE: 2031000.00
BCAX balance_sheet (quarterly, 2025-12-31) — Net PPE: 2031000.00
BCAX cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -280000.00
BCAX cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -238000.00
BCAX balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 401452000.00
BCAX balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 401452000.00
BCAX income_statement (annual, 2025-12-31) — Normalized EBITDA: -155499000.00
BCAX income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -41079000.00
BCAX income_statement (annual, 2025-12-31) — Normalized Income: -137950000.00
BCAX income_statement (quarterly, 2025-12-31) — Normalized Income: -37386000.00
BCAX cash_flow (annual, 2025-12-31) — Operating Cash Flow: -106834000.00
BCAX cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -23886000.00
BCAX income_statement (annual, 2025-12-31) — Operating Income: -155604000.00
BCAX income_statement (quarterly, 2025-12-31) — Operating Income: -41122000.00
BCAX income_statement (annual, 2025-12-31) — Operating Revenue: 0.00
BCAX income_statement (quarterly, 2025-12-31) — Operating Revenue: 0.00
BCAX balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 56600724.00
BCAX balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 56600724.00
BCAX balance_sheet (annual, 2025-12-31) — Other Current Assets: 7252000.00
BCAX balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 7252000.00
BCAX balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 243000.00
BCAX balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 243000.00
BCAX income_statement (annual, 2025-12-31) — Other Gand A: 9926000.00
BCAX income_statement (quarterly, 2025-12-31) — Other Gand A: 2426000.00
BCAX cash_flow (annual, 2025-12-31) — Other Non Cash Items: 895000.00
BCAX cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 297000.00
BCAX balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 6910000.00
BCAX balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 6910000.00
BCAX balance_sheet (annual, 2025-12-31) — Other Properties: 2031000.00
BCAX balance_sheet (quarterly, 2025-12-31) — Other Properties: 2031000.00
BCAX balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 318116000.00
BCAX balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 318116000.00
BCAX balance_sheet (annual, 2025-12-31) — Payables: 7793000.00
BCAX balance_sheet (quarterly, 2025-12-31) — Payables: 7793000.00
BCAX balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 22791000.00
BCAX balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 22791000.00
BCAX balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 5041000.00
BCAX balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 5041000.00
BCAX balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
BCAX balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
BCAX income_statement (annual, 2025-12-31) — Pretax Income: -137733000.00
BCAX income_statement (quarterly, 2025-12-31) — Pretax Income: -37333000.00
BCAX cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 2763000.00
BCAX cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 1732000.00
BCAX cash_flow (annual, 2025-12-31) — Purchase Of Investment: -318173000.00
BCAX cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -82094000.00
BCAX cash_flow (annual, 2025-12-31) — Purchase Of PPE: -280000.00
BCAX cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -238000.00
BCAX income_statement (annual, 2025-12-31) — Reconciled Depreciation: 105000.00
BCAX income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 43000.00
BCAX income_statement (annual, 2025-12-31) — Research And Development: 125096000.00
BCAX income_statement (quarterly, 2025-12-31) — Research And Development: 32990000.00
BCAX balance_sheet (annual, 2025-12-31) — Retained Earnings: -358966000.00
BCAX balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -358966000.00
BCAX income_statement (annual, 2025-12-31) — Salaries And Wages: 20582000.00
BCAX income_statement (quarterly, 2025-12-31) — Salaries And Wages: 5706000.00